Latest News

Love your Lungs

 Love your Lungs Campaign

On Monday the 13th of February a group of Irish charities have teamed up with Olympic Champion Dr Ronnie Delany to promote healthy lungs by highlighting symptoms of lung disease and the importance of early intervention.  The Irish Lung Health Alliance includes:

  • Irish Thoracic Society
  • Cystic Fibrosis Association of Ireland
  • Irish Lung Fibrosis Association
  • Ben Bulben COPD Support Group
  • Irish Sleep Apnoea Trust
  • Asthma Society of Ireland
  • the Irish Cancer Society
  • Irish Sarcoidosis Network

 

The Love your Lungs campaign carries four simple messages:
1. Lung disease can affect anyone regardless of age, health status and walk of life
2. Symptoms such as persistent cough and shortness of breath are not normal and should be checked with your GP
3. Lung disease is treatable – the earlier you treat the better.
4. Keep lungs healthy - don’t smoke and stay active


The ‘Love Your Lungs’ campaign will see the charities working with medical centres throughout the country to offer free lung function tests for World Spirometry Day taking place in June this year.  It also incorporates a new website, www.lunghealth.ie, offering helpful information and advice regarding common lung conditions as well as patient support and tips on how to keep your lungs healthy.  The website will be updated regularly with details on participating centres over the coming months.

One in five deaths in Ireland is caused by lung disease.  It is the most common reason to visit a GP and the third most common reason for acute hospital admission.  Yet early diagnosis of lung disease, which can vastly improve outcomes and quality of life for patients, continues to be a challenge due to poor awareness levels.  The fact is, shortness of breath, cough and wheeze are not normal and if present should be checked out by your GP,’ said Dr Edward McKone, Consultant Respiratory Physician and President of the Irish Thoracic Society.


‘The campaign also aims to highlight the fact that lung disease affects people of all ages, all socio-economic backgrounds and many non-smokers as well as smokers.  ‘The range of conditions represented by The Lung Health Alliance charities is evidence of the broad-reaching nature of lung disease as they affect everyone from infants to senior citizens.  In fact lung disease is the most prevalent condition reported in young adults (18-24 years of age),’ said Dr McKone.

Olympic legend Dr Ronnie Delany is an ambassador for the campaign underlining the importance of healthy lungs to an active lifestyle and visa versa.  As an Olympic Gold Medallist and the winner of an unprecedented and unsurpassed 40 straight victories “indoors” in America from 1956 to 1959 including 33 mile races,  Dr Delany embodies the link between good lung function and athleticism.


 “We know only too well how dependent athletes are on good lung function. What’s probably less well known is the reverse – the role that sport and physical activity can play in preventing lung disease and in improving quality of life for people with lung conditions. It’s therefore very fitting that the Irish Lung Health Alliance and the World Spirometry Day Campaign have chosen this Olympics year to launch their campaign, said Dr Delany”

 

 

Patient Support Group



Thank You
Wednesday, 19 October 2011 11:16
The Annual Alpha One Patient's Meeting was a big success. Thanks to all the patients that turned up on the day. The Alpha One Patient Support group had a successful meeting in the afternoon. They discussed future fundraising and awareness projects and got plenty of ideas from Angela McBride, Director of Development, Alpha-1 Foundation, USA. If anyone would like to get involved in further fundraising or has any ideas, please contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or Phone: 01-8093871.
         
 
Annual Alpha-1 Patient Meeting 2009
Monday, 12 October 2009 09:50

The annual Alpha-1 patient meeting will be held on Saturday 10th October at 10.30am in Marino Institute of Education on Griffith Avenue, Dublin 9. All Alpha-1 patients and their families are invited to attend this forum. Invited speakers will be discussing issues relevant to Alpha-1 patients, including disease management, current research, and ongoing clinical trials in Beaumont Hospital.

Read more...
 
Annual Patient Meeting
Wednesday, 07 October 2009 13:18

The annual Alpha-1 patient meeting will be held on Saturday 10th October at 10.30am in Marino Institute of Education on Griffith Avenue, Dublin 9. All Alpha-1 patients and their families are invited to attend this forum. Invited speakers will be discussing issues relevant to Alpha-1 patients, including disease management, current research, and ongoing clinical trials in Beaumont Hospital.

Read more...
 
Patient Support Group
Wednesday, 30 July 2008 09:43

Since April 2008 the Patient Support Group has organised five meetings, all members receive minutes and agenda of these meetings. These were held in the Alpha One Foundation’s office located in the RCSI Building at Beaumont Hospital. This venue can be changed at any time as organised by the group. Items discussed range from awareness to feedback of delegates to international patient meetings e.g. Prague in May 2008. Attendance has been low recently but we hope to improve this with an awareness campaign in October 2008. We would encourage patients to keep in contact with other patients and we hope to develop a newsletter updating members of news events and patient stories.

Read more...
 


What is Alpha-1 Antitrypsin?

Alpha-1 Antitrypsin is an important protein produced by the liver, which is released into the bloodstream and travels to the lungs.  Once inside the lungs it provides protection from the destructive effects of infections and harmful irritants, particularly tobacco smoke.

Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, along with cystic fibrosis, is the commonest genetic lung disease in Ireland. It severely affects more than 2,000 people nationally, with another 10,000 individuals also at risk of lung and liver disease. It is the only proven genetic risk factor for COPD.